Lowe Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $103K | Sell |
557
-33
| -6% | -$5.65K | 0.04% | 95 |
|
|
2025
Q2 | $90.1K | Sell |
590
-124
| -17% | -$19.1K | 0.04% | 99 |
|
|
2025
Q1 | $118K | Buy |
714
+101
| +16% | +$15.8K | 0.05% | 81 |
|
|
2024
Q4 | $88.6K | Buy |
613
+2
| +0.3% | +$310 | 0.04% | 93 |
|
|
2024
Q3 | $98.9K | Sell |
611
-35
| -5% | -$5.58K | 0.04% | 77 |
|
|
2024
Q2 | $94.4K | Sell |
646
-12
| -2% | -$1.78K | 0.04% | 79 |
|
|
2024
Q1 | $104K | Sell |
658
-88
| -12% | -$14K | 0.05% | 77 |
|
|
2023
Q4 | $117K | Sell |
746
-311
| -29% | -$47.7K | 0.06% | 70 |
|
|
2023
Q3 | $165K | Sell |
1,057
-18
| -2% | -$2.97K | 0.09% | 58 |
|
|
2023
Q2 | $178K | Buy |
1,075
+53
| +5% | +$8.55K | 0.09% | 56 |
|
|
2023
Q1 | $158K | Sell |
1,022
-112
| -10% | -$18.1K | 0.09% | 53 |
|
|
2022
Q4 | $200K | Buy |
1,134
+152
| +15% | +$26.2K | 0.11% | 48 |
|
|
2022
Q3 | $160K | Buy |
982
+152
| +18% | +$25.7K | 0.09% | 47 |
|
|
2022
Q2 | $147K | Buy |
830
+2
| +0.2% | +$356 | 0.08% | 51 |
|
|
2022
Q1 | $147K | Buy |
828
+221
| +36% | +$37.6K | 0.07% | 54 |
|
|
2021
Q4 | $104K | Buy |
607
+1
| +0.2% | +$164 | 0.05% | 68 |
|
|
2021
Q3 | $98K | Sell |
606
-15
| -2% | -$2.56K | 0.05% | 65 |
|
|
2021
Q2 | $102K | Hold |
621
| – | – | 0.05% | 65 |
|
|
2021
Q1 | $102K | Sell |
621
-6
| -1% | -$971 | 0.05% | 60 |
|
|
2020
Q4 | $99K | Buy |
627
+1
| +0.2% | +$148 | 0.05% | 54 |
|
|
2020
Q3 | $93K | Hold |
626
| – | – | 0.05% | 51 |
|
|
2020
Q2 | $88K | Buy |
626
+1
| +0.2% | +$146 | 0.05% | 49 |
|
|
2020
Q1 | $82K | Sell |
625
-52
| -8% | -$7.38K | 0.06% | 46 |
|
|
2019
Q4 | $99K | Sell |
677
-20
| -3% | -$2.71K | 0.06% | 46 |
|
|
2019
Q3 | $90K | Sell |
697
-124
| -15% | -$16.3K | 0.05% | 45 |
|
|
2019
Q2 | $114K | Buy |
821
+276
| +51% | +$38.2K | 0.07% | 39 |
|
|
2019
Q1 | $76K | Buy |
545
+35
| +7% | +$4.69K | 0.05% | 49 |
|
|
2018
Q4 | $66K | Hold |
510
| – | – | 0.05% | 49 |
|
|
2018
Q3 | $70K | Buy |
510
+1
| +0.2% | +$133 | 0.04% | 50 |
|
|
2018
Q2 | $62K | Buy |
509
+1
| +0.2% | +$125 | 0.04% | 53 |
|
|
2018
Q1 | $65K | Hold |
508
| – | – | 0.04% | 53 |
|
|
2017
Q4 | $71K | Hold |
508
| – | – | 0.04% | 52 |
|
|
2017
Q3 | $66K | Buy |
508
+101
| +25% | +$13.4K | 0.04% | 53 |
|
|
2017
Q2 | $54K | Hold |
407
| – | – | 0.03% | 61 |
|
|
2017
Q1 | $51K | Hold |
407
| – | – | 0.03% | 59 |
|
|
2016
Q4 | $47K | Sell |
407
-400
| -50% | -$46.2K | 0.03% | 60 |
|
|
2016
Q3 | $95K | Buy |
807
+400
| +98% | +$48.5K | 0.06% | 44 |
|
|
2016
Q2 | $49K | Buy |
407
+28
| +7% | +$3.18K | 0.03% | 58 |
|
|
2016
Q1 | $41K | Hold |
379
| – | – | 0.03% | 61 |
|
|
2015
Q4 | $39K | Hold |
379
| – | – | 0.03% | 60 |
|
|
2015
Q3 | $35K | Buy |
379
+50
| +15% | +$4.84K | 0.03% | 63 |
|
|
2015
Q2 | $32K | Hold |
329
| – | – | 0.02% | 84 |
|
|
2015
Q1 | $33K | Buy |
329
+50
| +18% | +$5.08K | 0.02% | 82 |
|
|
2014
Q4 | $29K | Buy |
+279
| New | +$29.4K | 0.02% | 84 |
|
Other funds holding JNJ
Lowe Wealth Advisors's JNJ Position: Q3 2025 in Review
Lowe Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 5.6% in Q3 2025, selling an estimated $5.65K and leaving 557 shares worth $103K. The position accounts for 0.04% of the portfolio, ranked #95.
Lowe Wealth Advisors first reported a position in JNJ in Q4 2014 and has held it in 44 quarters since. The position peaked at $200K in Q4 2022. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.
- Lowe Wealth Advisors held 557 shares of Johnson & Johnson worth $103K as of Q3 2025.
- Lowe Wealth Advisors sold 33 Johnson & Johnson shares in Q3 2025, an estimated $5.65K.
- Johnson & Johnson made up 0.04% of Lowe Wealth Advisors's portfolio in Q3 2025, its #95 holding.
- Lowe Wealth Advisors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 44 quarters since.
- Lowe Wealth Advisors's Johnson & Johnson position peaked at $200K in Q4 2022.
- 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.
Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.